Any BP that is confident this is worth $5+ won't wait til the SP is there in a year to offer when it's a buck now. Denner listed his Buy It Now price yesterday.
"The drug is worth at least $5 per share to a Big Pharma. But they will be stingy. Because they can be. They can smell the stink of vulnerability on this thing. "
This is true unless they are aware of the fact that more than one BP has interest. Then greed "which is a wonderful thing in this case" takes over :-)